Champions Oncology (CSBR) EPS (Basic) Growth (3y) (2014 - 2026)
Champions Oncology (CSBR) EPS (Basic) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | -38.31% |
| 10 | Champions Oncology | 69.02 Mn | 69.02 Mn | 7.03 Mn | 36.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 36.59% |
| Jan 31, 2026 | 51.84% |
| Oct 31, 2025 | 154.74% |
| Jul 31, 2025 | -12.73% |
| Apr 30, 2025 | -72.73% |
| Jan 31, 2025 | 77.88% |
| Oct 31, 2024 | 37.44% |
| Jul 31, 2024 | 111.98% |
| Apr 30, 2024 | 46.04% |
| Jan 31, 2024 | -66.25% |
| Oct 31, 2023 | -1,161.30% |
| Jul 31, 2023 | -224.72% |
| Apr 30, 2023 | -1.14% |
| Jan 31, 2023 | -93.05% |
| Oct 31, 2022 | -26.93% |
| Jul 31, 2022 | 24.66% |
| Apr 30, 2022 | -5.32% |
| Jan 31, 2022 | 56.30% |
| Oct 31, 2021 | -4.49% |
| Jul 31, 2021 | -31.87% |